植物化学概况和Garcinia celebica的多样化药理
Nor Hidayah Mustafa1, Juriyati Jalil1, Kai En Leong1
1Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia.
Heliyon
|May 14, 2024
概括
东南亚植物Garcinia celebica含有诸多植物化学物质,如三类和桑类. 这些化合物表现出多样化的药理活性,为新药开发提供了潜力.
科学领域:
- 民族植物学 民族植物学
- 药理学是指药理学,即药理学是指药理学.
- 药用化学 医学化学
背景情况:
- 格拉西尼亚 (Garcinia celebica) L. (同义词) 是一种植物. 皮埃尔 (Garcinia hombroniana Pierre) 是一种原产于东南亚的植物物种.
- 它属于Clusiaceae家族,具有传统的药用用途.
研究的目的:
- 编译和分类关于Garcinia celebica植物成分的最新信息.
- 审查该物种报告的药理效应.
主要方法:
- 在Scopus,谷歌学者,PubMed和Springer链接上进行文献搜索.
- 植物化学品及其相关生物活性的系统审查和分类.
主要成果:
- 确定了大约100种植物化学物质,包括三类,黄类,类,类,类,类和类.
- 三类和桑类是最丰富的化合物类.
- 报告的活动包括抗菌,抗寄生虫,肝保护,抗氧化,抗糖尿病,抗结核,抗血小板聚合,抗神经胺酶和胆酶抑制.
结论:
- 加尔西尼亚 (Garcinia celebica) 拥有丰富的植物化学物质,具有广泛的药理学活性.
- 这篇评论强调了Garcinia celebica作为未来药物发现和开发的宝贵资源的潜力.
相关概念视频
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
744
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
744
Pharmacogenetics and Pharmacogenomics: Overview
264
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
264
Principles of Pharmacogenetics: Types of Genetic Variants
143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
Pharmacogenetics of Drug Metabolism: Overview
196
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
196
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


